...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The journal of obstetrics and gynaecology research >Low molecular weight heparin and pregnancy outcomes in women with inherited thrombophilia: A systematic review and meta‐analysis
【24h】

Low molecular weight heparin and pregnancy outcomes in women with inherited thrombophilia: A systematic review and meta‐analysis

机译：Low molecular weight heparin and pregnancy outcomes in women with inherited thrombophilia: A systematic review and meta‐analysis

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相关主题

摘要

Abstract Aim To determine whether the use of low molecular weight heparin (LMWH) improves the pregnancy outcomes in women with inherited thrombophilia by conducting a meta‐analysis of randomized controlled trials and observational studies. Methods A systematic literature search of several databases was conducted through September 19, 2020 to identify relevant studies. The outcomes of interest included live birth and adverse pregnancy outcomes (APOs). The overall risk estimates were pooled using random‐effects meta‐analysis. Results Ten randomized controlled trials and 12 cohort studies were included. In the meta‐analyses of randomized controlled trials, the effectiveness of LMWH‐treatment was found to be statistically significant in decreasing the risk of APOs (risk ratio [RR]?=?0.76; 95% confidence interval [CI]: 0.61–0.95; p?=?0.020), rather than in increasing the rate of live birth (RR?=?1.12; 95% CI: 0.93–1.34; p?=?0.230). In the meta‐analyses of cohort studies, results showed that the use of LMWH was associated with a significantly higher proportion of live birth (RR?=?1.86; 95% CI: 1.09–3.19; p?=?0.020) as well as a significantly lower ratio of APOs (RR?=?0.46; 95% CI: 0.31–0.69; p?

著录项

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号